⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL2883490 | 0.97 | ADH1A (0.48) | — | |
| Ammonia Solution, Strong SCHEMBL2889106 | 0.97 | ADH1A (0.48) | — | |
| Ammonia Solution, Strong SCHEMBL2886729 | 0.97 | ADH1A (0.48) | — | |
| Ammonia Solution, Strong SCHEMBL2887232 | 0.97 | ADH1A (0.48) | — | |
| Ammonia Solution, Strong SCHEMBL2883120 | 0.97 | ADH1A (0.48) | — | |
| Ammonia Solution, Strong SCHEMBL2880821 | 0.97 | ADH1A (0.48) | — | |
| SCHEMBL284507 | 0.96 | — | — | |
| Ammonia Solution, Strong SCHEMBL29080997 | 0.96 | — | — | |
| SCHEMBL12036975 | 0.96 | ADH1A (0.46) | — | |
| SCHEMBL13356252 | 0.93 | ADH1A (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7670753-B2 | Lithographic printing plate precursor | EASTMAN KODAK COMPANY (US) | 2010-03-02 | — | — | US | disclosed |
| US-20080261146-A1 | Lithographic Printing Plate Precursor | EASTMAN KODAK COMPANY | 2008-10-23 | — | — | US | disclosed |
| EP-1782127-B1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR | EASTMAN KODAK CO (US) | 2008-04-02 | — | — | EP | disclosed |
| EP-1782127-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR | EASTMAN KODAK COMPANY (US) | 2007-05-09 | — | — | EP | disclosed |
| WO-2006023667-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR | EASTMAN KODAK COMPANY (US) | 2006-03-02 | — | — | WO | disclosed |